Clinical Trial Update: Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gemcitabine with or without capecitabine in locally advanced, unresectable, or metastatic biliary cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 3 | Status: TERMINATED